Kavita Gandhi

Kavita Gandhi

Auto-generated profile, based on publicly available information

Kavita Gandhi

Department of Emergency Medicine University of California San Francisco San Francisco California USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
AKAndre Kumar
Andre Kumar
YWYingjie Weng
Yingjie Weng
SGSally Graglia
Sally Graglia
SCSukyung Chung
Sukyung Chung
YDYouyou Duanmu
Youyou Duanmu
JKJohn Kugler
John Kugler
Background: Lung ultrasound (LUS) has received considerable interest in the clinical evaluation of patients with COVID‐19. Previously described LUS manifestations for COVID‐19 include B‐lines, consolidations, and pleural thickening. The interrater reliability (IRR) of these findings for COVID‐19 is unknown.Methods: This study was conducted between March and June 2020. Nine physicians (hospitalists: n = 4; emergency medicine: n = 5) from 3 medical centers independently evaluated n = 20 LUS scans (n = 180 independent observations) collected from patients with COVID‐19, diagnosed via RT‐PCR. These studies were randomly selected from an image database consisting of COVID‐19 patients evaluated in the emergency department with portable ultrasound devices. Physicians were blinded to any patient information or previous LUS interpretation. Kappa values (κ) were used to calculate IRR.Results: There was substantial IRR on the following items: normal LUS scan (κ = 0.79 [95% CI: 0.72–0.87]), presence of B‐lines (κ = 0.79 [95% CI: 0.72–0.87]), ≥3 B‐lines observed (κ = 0.72 [95% CI: 0.64–0.79]). Moderate IRR was observed for the presence of any consolidation (κ = 0.57 [95% CI: 0.50–0.64]), subpleural consolidation (κ = 0.49 [95% CI: 0.42–0.56]), and presence of effusion (κ = 0.49 [95% CI: 0.41–0.56]). Fair IRR was observed for pleural thickening (κ = 0.23 [95% CI: 0.15–0.30]).Discussion: Many LUS manifestations for COVID‐19 appear to have moderate to substantial IRR across providers from multiple specialties utilizing differing portable devices.The most reliable LUS findings with COVID‐19 may include the presence/count of B‐lines or determining if a scan is normal. Clinical protocols for LUS with COVID‐19 may require additional observers for the confirmation of less reliable findings such as consolidations.

1 September 2021 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
AKAndre Kumar
Andre Kumar
IWIsabel Weng
Isabel Weng
SGSally Graglia
Sally Graglia
TLThomas Lew
Thomas Lew
KGKavita Gandhi
Kavita Gandhi
JKJohn Kugler
John Kugler
Objectives: Point‐of‐care ultrasound (POCUS) detects the pulmonary manifestations of COVID‐19 and may predict patient outcomes.Methods: We conducted a prospective cohort study at four hospitals from March 2020 to January 2021 to evaluate lung POCUS and clinical outcomes of COVID‐19. Inclusion criteria included adult patients hospitalized for COVID‐19 who received lung POCUS with a 12‐zone protocol.Each image was interpreted by two reviewers blinded to clinical outcomes. Our primary outcome was the need for intensive care unit (ICU) admission versus no ICU admission. Secondary outcomes included intubation and supplemental oxygen usage.Results: N = 160 patients were included. Among critically ill patients, B‐lines (94 vs 76%;P < .01) and consolidations (70 vs 46%;P < .01) were more common. For scans collected within 24 hours of admission (N = 101 patients), early B‐lines (odds ratio [OR] 4.41 [95% confidence interval, CI: 1.71–14.30];P < .01) or consolidations (OR 2.49 [95% CI: 1.35–4.86];P < .01) were predictive of ICU admission. Early consolidations were associated with oxygen usage after discharge (OR 2.16 [95% CI: 1.01–4.70];P = .047). Patients with a normal scan within 24 hours of admission were less likely to require ICU admission (OR 0.28 [95% CI: 0.09–0.75];P < .01) or supplemental oxygen (OR 0.26 [95% CI: 0.11–0.61];P < .01). Ultrasound findings did not dynamically change over a 28‐day scanning window after symptom onset.Conclusions: Lung POCUS findings detected within 24 hours of admission may provide expedient risk stratification for important COVID‐19 clinical outcomes, including future ICU admission or need for supplemental oxygen. Conversely, a normal scan within 24 hours of admission appears protective. POCUS findings appeared stable over a 28‐day scanning window, suggesting that these findings, regardless of their timing, may have clinical implications.

1 August 2019 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
KGKavita Gandhi
Kavita Gandhi
WSWilliam Shyy
William Shyy
SKStarr Knight
Starr Knight
NTNathan Teismann
Nathan Teismann

5 March 2021 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
AKAndre Kumar
Andre Kumar
YWYingjie Weng
Yingjie Weng
YDYouyou Duanmu
Youyou Duanmu
SGSally Graglia
Sally Graglia
FLFarhan Lalani
Farhan Lalani
JKJohn Kugler
John Kugler
Objectives: Lung ultrasound (LUS) can accurately diagnose several pulmonary diseases, including pneumothorax, effusion, and pneumonia. LUS may be useful in the diagnosis and management of COVID‐19.Methods: This study was conducted at two United States hospitals from 3/21/2020 to 6/01/2020. Our inclusion criteria included hospitalized adults with COVID‐19 (based on symptomatology and a confirmatory RT‐PCR for SARS‐CoV‐2) who received a LUS. Providers used a 12‐zone LUS scanning protocol. The images were interpreted by the researchers based on a pre‐developed consensus document. Patients were stratified by clinical deterioration (defined as either ICU admission, invasive mechanical ventilation, or death within 28 days from the initial symptom onset) and time from symptom onset to their scan.Results: N = 22 patients (N = 36 scans) were included. Eleven (50%) patients experienced clinical deterioration. Among N = 36 scans, only 3 (8%) were classified as normal. The remaining scans demonstrated B‐lines (89%), consolidations (56%), pleural thickening (47%), and pleural effusion (11%). Scans from patients with clinical deterioration demonstrated higher percentages of bilateral consolidations (50 versus 15%; P = .033), anterior consolidations (47 versus 11%; P = .047), lateral consolidations (71 versus 29%; P = .030), pleural thickening (69 versus 30%; P = .045), but not B‐lines (100 versus 80%; P = .11). Abnormal findings had similar prevalences between scans collected 0–6 days and 14–28 days from symptom onset.Discussion: Certain LUS findings may be common in hospitalized COVID‐19 patients, especially for those that experience clinical deterioration. These findings may occur anytime throughout the first 28 days of illness. Future efforts should investigate the predictive utility of these findings on clinical outcomes.

28 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
AKAndre Kumar
Andre Kumar
SCSukyung Chung
Sukyung Chung
YDYouyou Duanmu
Youyou Duanmu
SGSally Graglia
Sally Graglia
FLFarhan Lalani
Farhan Lalani
JKJohn Kugler
John Kugler
Introduction: Point-of-care ultrasound (POCUS) has the potential to transform healthcare delivery in the era of COVID-19 with its diagnostic and therapeutic expediency. It can be performed by clinicians already at the bedside, which permits an immediate and augmented assessment of a patient. Although lung ultrasound can be used to accurately diagnose a variety of disease states such as pneumothorax, pleural effusions, pneumonia and interstitial lung disease2, there are limited reports on the sonographic manifestations of COVID-19. There is an urgent need to identify alternative diagnostic modalities that can be immediately employed at the bedside of COVID-19 patients. Methods: This study was conducted at two medical centers in the United States from 3/21/2020-6/01/2020. Any adult who was hospitalized with COVID-19 (based on symptomatology and a confirmatory RT-PCR for SARS-CoV-2) and received a pulmonary POCUS examination was included. Providers were instructed to use a 12-zone scanning protocol for pulmonary views and save 6 second clips of each lung zone. This study utilized several POCUS devices, including Butterfly IQ, Vave, Lumify, and Sonosite. The collected images were interpreted by the study researchers based on a consensus document developed by the study authors and previously accepted definitions of lung POCUS findings. Results: A total of 22 eligible patients who received 36 lung scans were included in our study. Eleven (50%) patients experienced clinical deterioration (defined as either ICU admission, invasive mechanical ventilation, or death within 28 days from the initial symptom onset). Among the 36 lung scans collected, only 3 (8%) were classified as normal. The remaining scans had the following abnormalities: presence of B-lines (n=32, 89%), consolidations (n=20, 56%), pleural thickening (n=17, 47%), and pleural effusion (n=4, 11%). Out of 20 scans with consolidations, 14 (70%) were subpleural and 5 (25%) were translobar. A-lines were present in 26 (72%) of patients, although they were only observed in the majority of the collected lung zones in 5 (14%) of patients. Ultrasound findings were stratified by time from symptom onset to the scan based on the following time periods: early (0-6 days), middle (7-13 days), and late (14-28 days). B-lines appeared early after symptom onset and persisted well into the late disease course. In contrast, pleural thickening increased in frequency over time (early: 25%, middle: 47%, late: 67%). Subpleural consolidations also appeared in higher frequency later in the disease course (early: 13%, middle 42%, late: 56%). Discussion: certain lung ultrasound findings may be common in Covid-19, while others may appear later in the disease course or only occur in patients who experience clinical deterioration. Future efforts should investigate the predictive utility of consolidations, pleural thickening and B-lines for clinical deterioration and compare them to traditional radiological studies such as X-rays or CTs.

23 November 2021 in Emergency Medicine Journal
Verified
Journal Article
Closed access
PDF file
NANancy Anaya
Nancy Anaya
KGKavita Gandhi
Kavita Gandhi
SGSally Graglia
Sally Graglia
The patient denies any medical history. He has never had any surgeries. He is not taking any medications and has no allergies.